Filter Results
:
(4,980)
Show Results For
-
All HBS Web
(4,980)
- People (17)
- News (1,891)
- Research (2,302)
- Events (2)
- Multimedia (205)
- Faculty Publications (1,804)
Show Results For
-
All HBS Web
(4,980)
- People (17)
- News (1,891)
- Research (2,302)
- Events (2)
- Multimedia (205)
- Faculty Publications (1,804)
- September 8, 2020
- Article
Allocation of COVID-19 Relief Funding to Disproportionately Black Counties
By: Pragya Kakani, Amitabh Chandra and Sendhil Mullainathan
This study describes correlations between the dollar amount of relief funding authorized by the US Congress to fund prevention, diagnosis, and treatment of coronavirus disease 2019 (COVID-19) and to reimburse health care entities for lost revenues, and county-level...
View Details
Kakani, Pragya, Amitabh Chandra, and Sendhil Mullainathan. "Allocation of COVID-19 Relief Funding to Disproportionately Black Counties." JAMA, the Journal of the American Medical Association 324, no. 10 (September 8, 2020): 1000–1003.
- 06 Apr 2021
- News
Day of 4 Million Vaccines Signals Sharp Turnaround for U.S.
- 23 Feb 2017
- News
The power — and the fear — of knowing your cancer genome
- 18 Dec 2017
- News
Hospital Giants Vie for Patients in Effort to Fend Off New Rivals
- 04 Oct 2013
- News
Medical Device Tax Might Be Way To Get A Budget Passed
- 24 Apr 2019
- News
The Fallacy of Medicare for All
- June 2008
- Case
Brigham and Women's Hospital: Shapiro Cardiovascular Center
By: Michael E. Porter, Robert S. Huckman and Jeremy Lance Friese
Considers the situation facing Gary Gottlieb, president of Brigham and Women's Hospital (BWH), prior to the opening of BWH's integrated cardiovascular center. This case allows students to develop an appreciation of the strategic, financial, organizational, clinical,...
View Details
Keywords:
Health Care and Treatment;
Health Disorders;
Service Delivery;
Organizational Design;
Integration;
Health Industry
Porter, Michael E., Robert S. Huckman, and Jeremy Lance Friese. "Brigham and Women's Hospital: Shapiro Cardiovascular Center." Harvard Business School Case 608-175, June 2008.
- August 2015
- Article
Hospital Board and Management Practices Are Strongly Related to Hospital Performance on Clinical Quality Metrics
By: Thomas C Tsai, Ashish K. Jha, Atul A. Gawande, Robert S. Huckman, Nicholas Bloom and Raffaella Sadun
National policies to improve health care quality have largely focused on clinical provider outcomes and, more recently, payment reform. Yet the association between hospital leadership and quality, although crucial to driving quality improvement, has not been explored...
View Details
Keywords:
Hospitals;
Quality;
Governing and Advisory Boards;
Management Practices and Processes;
Service Delivery;
Health Care and Treatment;
Health Industry
Tsai, Thomas C., Ashish K. Jha, Atul A. Gawande, Robert S. Huckman, Nicholas Bloom, and Raffaella Sadun. "Hospital Board and Management Practices Are Strongly Related to Hospital Performance on Clinical Quality Metrics." Health Affairs 34, no. 8 (August 2015): 1304–1311.
- 23 Mar 2010
- News
Richard Bohmer on the Passage of U.S. Healthcare Reform Legislation
- 25 Jul 2009
- News
Some Inconvenient Truths About Medicare and the New 'Public Plan'
- 03 Feb 2015
- Working Paper Summaries
Regulator Leniency and Mispricing in Beneficent Nonprofits
- 11 Mar 2015
- News
Paying more for comparable outcomes in prostate treatment
- 27 Aug 2013
- First Look
First Look: August 27
https://pubwww.hbs.edu/faculty/Pages/item.aspx?num=45271 August 2013 Journal of Health Economics Consumers' Misunderstanding of Health Insurance By: Loewenstein, George, Joelle Y. Friedman, Barbara McGill, Sarah...
View Details
Keywords:
Sean Silverthorne
- November 2014 (Revised May 2017)
- Teaching Note
Fresno's Social Impact Bond for Asthma
By: John A. Quelch
The case desccribes a social impact bond (SIB) to fund home-based remediation programs designed to reduce asthma attacks among Fresno residents (especially children) and thereby save on health care costs (ambulance callouts, emergency room visits etc.). The case...
View Details
- Article
One Obstacle to Curing Cancer: Patient Data Isn't Shared
By: Richard G. Hamermesh and Kathy Giusti
Precision Medicine requires large datasets to identify the mutations that lead to various cancers. Currently, genomic information is hoarded in fragmented silos within numerous academic medical centers, pharmaceutical companies, and some disease-based foundations. For...
View Details
Keywords:
Healthcare;
Technological And Scientific Innovation;
Cancer Care In The U.S.;
Cancer Treatment;
Precision Medicine;
Personalized Medicine;
Data Sharing;
Technological Innovation;
Analytics and Data Science;
Health Disorders;
Medical Specialties;
Research and Development;
Customization and Personalization;
Health Industry;
United States
Hamermesh, Richard G., and Kathy Giusti. "One Obstacle to Curing Cancer: Patient Data Isn't Shared." Harvard Business Review (website) (November 28, 2016).
- 30 Jun 2015
- Video
Gender Differences in Health, Wellness, and Healthcare
- July 2002 (Revised March 2003)
- Case
North East Medical Services
By: Thomas J. DeLong and Wendy Carter
Sophie Wong, president and CEO of North East Medical Services, a health care organization dedicated to serving the underprivileged Asian American community in San Francisco, must decide how to reposition the organization to serve patients from multiple income levels...
View Details
Keywords:
Health Care and Treatment;
Human Resources;
Leadership;
Business and Stakeholder Relations;
Health Industry;
San Francisco
DeLong, Thomas J., and Wendy Carter. "North East Medical Services." Harvard Business School Case 403-002, July 2002. (Revised March 2003.)
- February 2015 (Revised November 2015)
- Supplement
Building an Integrated Biopharma Company: Crucell (B)
By: Richard G. Hamermesh, Marianne Van Der Steen and Susan Harmeling
The Crucell (B) case updates events at Crucell since 2009. In September, 2009, Johnson & Johnson acquired 18% of Crucell for $400 million. This investment was part of a business development deal. Subsequently, in 2012, Johnson & Johnson acquired Crucell for $2.8...
View Details
Keywords:
Biotechnology;
Biopharmacy Company;
Licensing Agreements In Biopharmacy;
Licensing;
Human Cell-line Technology;
Vaccine;
Healthcare Innovation;
Global Health;
Entrepreneurship;
Health Care and Treatment;
Acquisition;
Innovation and Invention;
Biotechnology Industry;
Pharmaceutical Industry
Hamermesh, Richard G., Marianne Van Der Steen, and Susan Harmeling. "Building an Integrated Biopharma Company: Crucell (B)." Harvard Business School Supplement 815-086, February 2015. (Revised November 2015.)